Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.

Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
复制标题

DOI:
10.1182/blood-2003-09-3286
复制
发表时间:
2004-05
期刊:
影响因子:
20.3
通讯作者:
K. Yamashita;U. Choi;Patricia C. Woltz;Susan F. Foster;M. Sneller;F. Hakim;D. Fowler;M. Bishop;S. Pavletic;M. Tamari;K. Castro;A. Barrett;R. Childs;G. Illei;S. Leitman;H. Malech;M. Horwitz
K. Yamashita;U. Choi;Patricia C. Woltz;Susan F. Foster;M. Sneller;F. Hakim;D. Fowler;M. Bishop;S. Pavletic;M. Tamari;K. Castro;A. Barrett;R. Childs;G. Illei;S. Leitman;H. Malech;M. Horwitz
中科院分区:
医学1区
文献类型:
--
作者:
K. Yamashita;U. Choi;Patricia C. Woltz;Susan F. Foster;M. Sneller;F. Hakim;D. Fowler;M. Bishop;S. Pavletic;M. Tamari;K. Castro;A. Barrett;R. Childs;G. Illei;S. Leitman;H. Malech;M. Horwitz

文献摘要

被引文献

相似文献

供体同种异体CD4(+) T细胞在慢性移植物抗宿主病(cGVHD)的发病机制中起重要作用,但导致GVHD的CD4(+) T细胞的特定亚群尚未确定。我们假设cGVHD可能与CD4(+)效应记忆细胞(CCR7(-)/CD62L(低),CD4(EM))的优势有关。我们分析了发生或未发生cGVHD的干细胞移植患者和健康供者CD4(+) T细胞上CCR7和CD62L的表达。cGVHD患者CD4(EM)细胞百分比(35.5% +/- 2.9%)高于健康供者(13.8% +/- 0.7%,P < 0.0001)或接受移植的无cGVHD患者(21.7% +/- 2.1%,P < 0.01)。使用皮质类固醇剂量作为cGVHD严重程度的替代标记,严重的cGVHD与较高的CD4(EM)细胞百分比相关。在皮质类固醇依赖的系统性狼疮红斑或韦格纳肉芽肿患者中,CD4(EM)细胞的比例与接受移植的无cGVHD患者没有差异。这一发现表明CD4(EM)细胞的过度表达是cGVHD的一个独特特征。
Donor alloreactive CD4(+) T cells are important to the pathogenesis of chronic graft-versus-host disease (cGVHD), but specific subsets of CD4(+) T cells responsible for GVHD have not been defined. We hypothesized that cGVHD might be associated with a preponderance of CD4(+) effector memory cells (CCR7(-)/CD62L(low), CD4(EM)). We analyzed CCR7 and CD62L expression on CD4(+) T cells from stem cell transplantation patients, who did or did not develop cGVHD, and healthy donors. Patients with cGVHD had a higher percentage of CD4(EM) cells (35.5% +/- 2.9%) than healthy donors (13.8% +/- 0.7%; P <.0001) or patients without cGVHD that received a transplant (21.7% +/- 2.1%; P <.01). Using corticosteroid dose as a surrogate marker for cGVHD severity, severe cGVHD was associated with a higher percentage of CD4(EM) cells. The proportion of CD4(EM) cells in corticosteroid-dependent patients with systemic lupus erythematosis or Wegener granulomatosis did not differ from patients without cGVHD that received a transplant. This finding implies that overrepresentation of CD4(EM) cells is a unique feature of cGVHD.